Standard BioToolsLAB

那斯達克 · USD
0.89
+0.01
(+1.18%)
盤中 06/12 01:30 (UTC+8)
06/12 01:30 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.28
  • 0.46
  • 0.37
  • 0.45
  • 1.08
  • 0.41
  • 0.22
  • 0.20
  • 0.24
  • 0.21
icon
  • 11.12
  • 61.56
  • -18.30
  • 20.87
  • 140.61
  • -62.30
  • 7.62
  • 1544.41
  • 21.70
  • -11.13
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
21,146
23,795
19,552
21,762
40,795
108,201
44,969
37,205
45,540
28,188
營業成本
9,83812,41310,06811,13421,05457,46521,70822,29721,35214,831
營業毛利
11,308
11,382
9,484
10,628
19,741
50,736
23,261
14,908
24,188
13,357
營業費用
23,80436,02642,42236,32552,711124,56954,97965,42784,37034,743
研發費用
2,1177,9696,3566,22211,32840,62013,15619,22215,9806,909
推銷及管理費用
18,60725,98226,63828,37639,83183,82339,48240,45664,10626,173
非經常性項目費用
3,0802,0759,4281,7271,5521262,3415,7494,2841,661
其他營業費用
----------
營業利益
-12,496
-24,644
-32,938
-25,697
-32,970
-73,833
-31,718
-50,519
-60,182
-21,386
其他收入及費用
-2,1192,618487,4266,788-4114,8983,82328,1536,015
利息費用
-510112572--1,033-4,567
稅前純益
-14,615
-22,031
-32,900
-18,282
-26,184
-74,816
-26,820
-45,663
-32,029
-19,938
所得稅
11-35,932-1,216-609-15130311855128-162
稅後純益
127,068
19,283
-34,687
-33,459
-26,033
-34,072
-26,938
-45,718
-32,157
-19,776
基本每股稅後盈餘(元)
0.330.05-0.09-0.09-0.07-0.09-0.07-0.12-0.27-0.25
稀釋每股稅後盈餘(元)
0.330.05-0.09-0.09-0.07-0.08-0.07-0.10-0.27-0.25
基本平均股數(千股)
388202.00385048.00382630.00380498.00378228.00374544.00371538.00372331.00294125.0079729.00
稀釋平均股數(千股)
388202.00385048.00382630.00380498.00378228.00374544.00371538.00372331.00294125.0079729.00
還原基本每股稅後盈餘(元)
0.330.05-0.09-0.09-0.07-0.09-0.07-0.12-0.27-0.25
還原稀釋每股稅後盈餘(元)
0.330.05-0.09-0.09-0.07-0.08-0.07-0.10-0.27-0.25
還原基本平均股數(千股)
388,202385,048382,630380,498378,228374,544371,538372,331294,12579,729
還原稀釋平均股數(千股)
388,202385,048382,630380,498378,228374,544371,538372,331294,12579,729
EBITDA(千元)
127,855-15,815-34,983-30,793-22,852-30,376-24,721-44,724-29,495-10,374

大家都在看

HOT